Corpus Intelligence IC Memo — CASEY COUNTY HOSPITAL 2026-04-26 15:58 UTC
IC Memo — CASEY COUNTY HOSPITAL
Investment Committee Memorandum | KY | 24 beds | Grade C | EBITDA uplift $2.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CASEY COUNTY HOSPITAL

CCN 181309 | CASEY, KY | 24 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CASEY COUNTY HOSPITAL is a 24-bed safety-net/medicaid heavy in CASEY, KY with $37.7M in net patient revenue and a 26.8% operating margin. The hospital serves a payer mix of 23.3% Medicare, 71.8% Medicaid, and 5.0% commercial.

Thesis: Turnaround. Our ML models identify $2.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 26.8% to 34.2% (+736bps).

Net Revenue HCRIS$37.7M
Current EBITDA COMPUTED$10.1M
Operating Margin COMPUTED26.8%
Occupancy HCRIS86.4%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS115.5%
Distress Probability ML63.1%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
49
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 26.8% places it above the state median. Among 49 size-comparable peers (12-48 beds), the median margin is -2.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-48), prioritizing same-state peers. 49 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CASEY COUNTY HOSPITAL (Target)KY24$37.7M26.8%
BAPTIST HEALTH LAGRANGEKY42$236.9M2.7%
FLAGET MEMORIAL HOSPITALKY40$86.2M-0.6%
ROCKCASTLE HOSPT. & RESPIR CARKY30$79.1M2.2%
HARRISON MEMORIAL HOSPITALKY34$67.8M-9.9%
SAINT JOSEPH MOUNT STERLINGKY42$64.2M-5.4%
OHIO COUNTY HOSPITALKY25$56.6M-6.8%
MUHLENBERG COMMUNITY HOSPITALKY47$49.4M-8.6%
BOURBON COMMUNITY HOSPITALKY34$44.0M16.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$793K+210bp18mo
Cost to Collect4.5%2.5%$755K+200bp12mo
Denial Rate Reduction12.0%6.5%$747K+198bp12mo
A/R Days Reduction5200.0%3800.0%$459K+122bp9mo
Clean Claim Rate88.0%96.0%$24K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$793K
Cost to Collect
$755K
Denial Rate Reduction
$747K
A/R Days Reduction
$459K
Clean Claim Rate
$24K
Total EBITDA Uplift$2.8M
Current EBITDA$10.1M
+ RCM Uplift+$2.8M
Pro Forma EBITDA$12.9M
Current Margin26.8%
Pro Forma Margin34.2%
WC Released (1x)$1.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$15.6M$94.6M6.07x43.4%
Base (11x exit)10.0x11.0x$15.6M$109.1M7.00x47.6%
Bull Case9.0x11.0x$14.0M$123.3M8.80x54.5%
Bull (12x exit)9.0x12.0x$14.0M$138.7M9.89x58.1%
Bear Case11.0x10.0x$17.1M$75.6M4.41x34.6%
Bear (11x exit)11.0x11.0x$17.1M$88.7M5.18x39.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumElevated Medicaid exposure (71.8%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 63.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 49 hospitals with 12-48 beds
  • Same-state prioritization (n=50)
  • Comp margins: P25=-11.0% / P50=-2.3% / P75=6.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.